Vanguard Group Inc Lixte Biotechnology Holdings, Inc. Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.51 - $1.89 $24,677 - $91,453	-48,388 Reduced 59.64%	32,745 $27,000
Q3 2022 Nov 14, 2022	SELL	$0.12 - $5.9 $339 - $16,667	-2,825 Reduced 3.36%	81,133 $45,000
Q1 2022 May 13, 2022	BUY	$0.16 - $0.35 $1,080 - $2,362	6,750 Added 8.74%	83,958 $103,000
Q4 2021 Feb 14, 2022	SELL	$0.21 - $0.57 $156 - $425	-747 Reduced 0.96%	77,208 $92,000
Q3 2021 Nov 12, 2021	BUY	$0.52 - $0.85 $1,857 - $3,036	3,572 Added 4.8%	77,955 $162,000
Q2 2021 Aug 13, 2021	BUY	$0.46 - $0.89 $34,216 - $66,200	74,383 New	74,383 $225,000

Ticker LIXT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,646,600
Market Cap $33M
Description
Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agent...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.